Bernard Chiasson

Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada.

Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.

Optum Biometrics, Inc. provides health screening services. The company is headquartered in

Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases. Their goal is to provide quality products that improve patient outcomes. Tribute is seeking to expand its product portfolio in Canada through strategic partnerships with other pharmaceutical, biotechnology and specialty pharmaceutical companies interested in gaining market experience in Canada.